FOXD1 promotes breast cancer proliferation and chemotherapeutic drug resistance by targeting p27.

Forkhead transcription factors are essential for diverse processes in early embryonic development and organogenesis. As a member of the forkhead family, FOXD1 is required during kidney development and its inactivation results in failure of nephron progenitor cells. However, the role of FOXD1 in carcinogenesis and progression is still limited. Here, we reported that FOXD1 is a potential oncogene in breast cancer. We found that FOXD1 is up-regulated in breast cancer tissues. Depletion of FOXD1 expression decreases the ability of cell proliferation and chemoresistance in MDA-MB-231 cells, whereas overexpression of FOXD1 increases the ability of cell proliferation and chemoresistance in MCF-7 cells. Furthermore, we observed that FOXD1 induces G1 to S phase transition by targeting p27 expression. Our results suggest that FOXD1 may be a potential therapy target for patients with breast cancer.

[1]  E. Nishida,et al.  Foxd1 is a mediator and indicator of the cell reprogramming process , 2014, Nature Communications.

[2]  A E Giuliano,et al.  FOXC1 regulates the functions of human basal-like breast cancer cells by activating NF-κB signaling , 2012, Oncogene.

[3]  Tony Hunter,et al.  p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21 , 1994, Cell.

[4]  Raymond Sawaya,et al.  FoxM1B is overexpressed in human glioblastomas and critically regulates the tumorigenicity of glioma cells. , 2006, Cancer research.

[5]  Ludger Hengst,et al.  The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy , 2008, Nature Reviews Cancer.

[6]  A. Giuliano,et al.  FOXC1 is a potential prognostic biomarker with functional significance in basal-like breast cancer. , 2010, Cancer research.

[7]  E. Batourina,et al.  Foxd1-dependent signals control cellularity in the renal capsule, a structure required for normal renal development , 2005, Development.

[8]  Zhiwei Wang,et al.  Down-regulation of Forkhead Box M1 transcription factor leads to the inhibition of invasion and angiogenesis of pancreatic cancer cells. , 2007, Cancer research.

[9]  A. Rudensky,et al.  Foxp3 programs the development and function of CD4+CD25+ regulatory T cells , 2003, Nature Immunology.

[10]  J. Whitsett,et al.  Foxm1 transcription factor is required for lung fibrosis and epithelial‐to‐mesenchymal transition , 2013, The EMBO journal.

[11]  E. Lam,et al.  The emerging roles of forkhead box (Fox) proteins in cancer , 2007, Nature Reviews Cancer.

[12]  Kaoru Tanaka,et al.  FOXQ1 is overexpressed in colorectal cancer and enhances tumorigenicity and tumor growth. , 2010, Cancer research.

[13]  J. Slingerland,et al.  Down-regulation of p21WAF1/CIP1 or p27Kip1 abrogates antiestrogen-mediated cell cycle arrest in human breast cancer cells. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[14]  Martin A Nowak,et al.  Evolution of Resistance During Clonal Expansion , 2006, Genetics.

[15]  Z. Fan,et al.  Protection against chemotherapy-induced cytotoxicity by cyclin-dependent kinase inhibitors (CKI) in CKI-responsive cells compared with CKI-unresponsive cells , 2001, Oncogene.

[16]  D. Accili,et al.  Regulation of insulin action and pancreatic β-cell function by mutated alleles of the gene encoding forkhead transcription factor Foxo1 , 2002, Nature Genetics.

[17]  M. Gottesman.  Mechanisms of cancer drug resistance. , 2002, Annual review of medicine.

[18]  Raymond Sawaya,et al.  FoxM1B transcriptionally regulates vascular endothelial growth factor expression and promotes the angiogenesis and growth of glioma cells. , 2008, Cancer research.

[19]  R. Vessella,et al.  FOXO1A is a candidate for the 13q14 tumor suppressor gene inhibiting androgen receptor signaling in prostate cancer. , 2006, Cancer research.

[20]  Qiang Yu,et al.  FOXQ1 regulates epithelial-mesenchymal transition in human cancers. , 2011, Cancer research.

[21]  Nicolai J. Birkbak,et al.  Chromosomal instability confers intrinsic multidrug resistance. , 2011, Cancer research.

[22]  James M. Roberts,et al.  Cloning of p27 Kip1 , a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals , 1994, Cell.

[23]  R. Iozzo,et al.  FOXD1 promotes nephron progenitor differentiation by repressing decorin in the embryonic kidney , 2014, Development.

[24]  P. Wijchers,et al.  In control of biology: of mice, men and Foxes. , 2006, The Biochemical journal.

[25]  Yonghong Xiao,et al.  FoxOs Are Lineage-Restricted Redundant Tumor Suppressors and Regulate Endothelial Cell Homeostasis , 2007, Cell.

[26]  Bin Zhang,et al.  Forkhead transcription factor foxq1 promotes epithelial-mesenchymal transition and breast cancer metastasis. , 2011, Cancer research.

[27]  V. Sheffield,et al.  The forkhead transcription factor gene FKHL7 is responsible for glaucoma phenotypes which map to 6p25 , 1998, Nature Genetics.

[28]  H. Nakagama,et al.  Cancer genetics and genomics of human FOX family genes. , 2013, Cancer letters.

[29]  A. McMahon,et al.  Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. , 2010, The American journal of pathology.